Panacea Biotec Ltd

PANACEABIO
Pharmaceuticals
โ‚น 521.20
Price
โ‚น 3,182
Market Cap
Small Cap
-
P/E Ratio

๐Ÿ“Š Score Snapshot

3.09 / 25
Performance
22.4 / 25
Valuation
0.0 / 20
Growth
7.0 / 30
Profitability
32.49 / 100
Avoid

๐Ÿข Company Overview

โณ Loading company overview...

๐Ÿค– CARL Insights

โณ Loading CARL insights...

๐Ÿ“ˆ Net Profit (Yearly)

๐Ÿ“Š Sales (Yearly)

๐Ÿ“‰ Quarterly Sales Trend

๐Ÿ“‰ Quarterly Net Profit

๐Ÿ“ˆ Yearly Ratios

Metric Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017
Adj Cash EBITDA 15.43 -388.54 298.83 108.96 -13.48 -2.05 113.44 136.90
Adj Cash EBITDA Margin 2.75 -83.22 48.62 17.92 -2.39 -0.42 18.99 26.05
Adj Cash EBITDA To EBITDA 2.69 7.53 -147.21 1.25 -0.16 0.02 1.23 1.46
Adj Cash EPS -10.23 -106.44 428.43 -20.77 -55.50 72.86 -8.57 -0.75
Adj Cash PAT -63.85 -653.24 2,626 -127.60 -339.95 446.92 -54.55 -6.09
Adj Cash PAT To PAT 0.87 2.07 1.13 0.85 1.40 1.40 0.72 0.12
Adj Cash PE - - 0.71 - - 8.43 - -
Adj EPS -11.80 -51.48 379.35 -24.34 -39.60 52.09 -12.07 -7.81
Adj EV To Cash EBITDA 42.82 - 1.35 17.02 - - 23.18 13.69
Adj EV To EBITDA 115.10 - - 21.31 16.22 - 28.58 20.02
Adj Number Of Shares 6.16 6.13 6.13 6.13 6.13 6.13 6.13 6.13
Adj PE - - 0.91 - - - - -
Bvps 137.01 137.84 142.58 -37.85 31.97 56.61 49.92 59.87
Cash Conversion Cycle 76.00 83.00 14.00 -80.00 -73.00 -328.00 195.00 259.00
Cash ROCE 4.45 -7.00 40.08 12.00 -0.08 1.92 7.34 7.50
Cash Roic 12.81 10.08 56.48 10.57 -3.35 1.47 6.22 4.08
Cash Revenue 561.96 466.89 614.66 608.14 564.11 491.74 597.46 525.56
Cash Revenue To Revenue 1.01 1.01 0.93 0.97 1.04 1.08 1.01 0.97
Dio 282.00 292.00 296.00 311.00 344.00 173.00 651.00 770.00
Dpo 244.00 256.00 327.00 440.00 463.00 572.00 540.00 607.00
Dso 37.00 48.00 45.00 49.00 46.00 71.00 84.00 95.00
EV 660.66 448.80 402.83 1,855 1,362 1,640 2,629 1,874
EV To EBITDA - - - 20.95 10.61 - 28.58 21.86
EV To Fcff 7.37 7.56 1.38 22.81 - 93.32 30.38 29.70
Fcfe -98.09 -630.01 1,873 -47.32 -184.16 461.17 -75.40 30.25
Fcfe Margin -17.45 -134.94 304.71 -7.78 -32.65 93.78 -12.62 5.76
Fcfe To Adj PAT 1.33 1.99 0.81 0.32 0.76 1.44 0.99 -0.61
Fcff 89.69 59.40 291.45 81.33 -33.51 17.57 86.54 63.08
Fcff Margin 15.96 12.72 47.42 13.37 -5.94 3.57 14.48 12.00
Fcff To NOPAT 0.79 0.17 -6.87 2.59 -2.79 -0.11 2.78 -2.60
Market Cap 814.66 664.80 953.83 1,168 713.47 1,019 1,715 911.53
PB 0.97 0.79 1.09 -5.03 3.64 2.94 5.61 2.48
PE - - 0.88 - - 27.02 - -
PS 1.46 1.45 1.44 1.87 1.31 2.23 2.89 1.68
ROCE 7.27 26.83 -4.58 5.46 4.63 -13.82 3.09 1.48
ROE -8.71 -36.80 724.33 830.61 -89.30 97.89 -22.59 -12.11
Roic 16.29 60.78 -8.22 4.08 1.20 -13.32 2.23 -1.57
Share Price 132.25 108.45 155.60 190.50 116.39 166.17 279.84 148.70

๐Ÿ“Š Quarterly Results

Metric Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021
Sales 163.49 147.35 115.72 136.46 150.50 143.02 129.19 128.93 115.20 105.12 110.70 140.73 155.88 232.17
Interest 0.99 0.98 0.87 0.82 0.85 0.91 1.00 1.05 0.96 1.18 1.25 30.66 52.13 50.16
Expenses - 155.53 140.35 129.71 142.50 150.65 146.58 139.50 134.60 123.84 108.96 190.51 170.92 144.02 226.15
Other Income - 3.62 4.65 3.80 10.81 5.68 3.23 6.08 15.06 13.94 10.45 12.21 4.05 1.66 2.03
Exceptional Items 2.77 2.77 2.74 2.74 2.78 2.77 27.74 19.38 27.77 27.77 27.74 1,676 - -
Depreciation 8.98 8.68 8.73 8.81 9.11 9.31 9.48 9.51 9.67 9.89 10.05 11.15 10.55 10.90
Profit Before Tax 4.38 4.76 -17.05 -2.12 -1.65 -7.78 13.03 18.21 22.44 23.31 -51.16 1,608 -49.16 -53.01
Tax % -1.37 1.05 6.86 6.13 -33.33 -6.56 15.73 169.63 13.68 32.65 -9.73 23.06 -0.08 -
Net Profit - 4.44 4.71 -15.88 -1.99 -2.20 -8.29 10.98 -12.68 19.37 15.70 -56.14 1,237 -49.20 -53.01
Minority Share - - - - - - - - - - - - - -
Exceptional Items At 3.00 3.00 3.00 3.00 2.00 3.00 26.00 -12.00 25.00 20.00 25.00 1,275 - -
Profit For PE 2.00 2.00 -19.00 -5.00 -4.00 -11.00 -15.00 -1.00 -5.00 -4.00 -81.00 -38.00 -49.00 -53.00
Profit For EPS 5.00 5.00 -16.00 -2.00 -2.00 -8.00 11.00 -13.00 19.00 16.00 -56.00 1,237 -49.00 -53.00
EPS In Rs 0.74 0.78 -2.59 -0.32 -0.37 -1.35 1.79 -2.07 3.16 2.56 -9.16 201.86 -8.03 -8.65
PAT Margin % 2.72 3.20 -13.72 -1.46 -1.46 -5.80 8.50 -9.83 16.81 14.94 -50.71 879.32 -31.56 -22.83
PBT Margin 2.68 3.23 -14.73 -1.55 -1.10 -5.44 10.09 14.12 19.48 22.17 -46.21 1,143 -31.54 -22.83
Tax -0.06 0.05 -1.17 -0.13 0.55 0.51 2.05 30.89 3.07 7.61 4.98 370.79 0.04 -
Yoy Profit Growth % 138.00 118.00 -27.00 -298.00 18.00 -144.00 82.00 97.00 89.00 92.00 -42.00 30.00 -23.00 -174.00
Adj Ebit 2.60 2.97 -18.92 -4.04 -3.58 -9.64 -13.71 -0.12 -4.37 -3.28 -77.65 -37.29 2.97 -2.85
Adj EBITDA 11.58 11.65 -10.19 4.77 5.53 -0.33 -4.23 9.39 5.30 6.61 -67.60 -26.14 13.52 8.05
Adj EBITDA Margin 7.08 7.91 -8.81 3.50 3.67 -0.23 -3.27 7.28 4.60 6.29 -61.07 -18.57 8.67 3.47
Adj Ebit Margin 1.59 2.02 -16.35 -2.96 -2.38 -6.74 -10.61 -0.09 -3.79 -3.12 -70.14 -26.50 1.91 -1.23
Adj PAT 7.25 7.45 -13.33 0.58 1.51 -5.34 34.36 -26.17 43.34 34.40 -25.70 2,527 -49.20 -53.01
Adj PAT Margin 4.43 5.06 -11.52 0.43 1.00 -3.73 26.60 -20.30 37.62 32.72 -23.22 1,796 -31.56 -22.83
Ebit -0.17 0.20 -21.66 -6.78 -6.36 -12.41 -41.45 -19.50 -32.14 -31.05 -105.39 -1,714 2.97 -2.85
EBITDA 8.81 8.88 -12.93 2.03 2.75 -3.10 -31.97 -9.99 -22.47 -21.16 -95.34 -1,702 13.52 8.05
EBITDA Margin 5.39 6.03 -11.17 1.49 1.83 -2.17 -24.75 -7.75 -19.51 -20.13 -86.12 -1,210 8.67 3.47
Ebit Margin -0.10 0.14 -18.72 -4.97 -4.23 -8.68 -32.08 -15.12 -27.90 -29.54 -95.20 -1,218 1.91 -1.23
NOPAT -1.03 -1.66 -21.16 -13.94 -12.35 -13.71 -16.68 10.57 -15.81 -9.25 -98.60 -31.81 1.31 -4.88
NOPAT Margin -0.63 -1.13 -18.29 -10.22 -8.21 -9.59 -12.91 8.20 -13.72 -8.80 -89.07 -22.60 0.84 -2.10
Operating Profit -1.02 -1.68 -22.72 -14.85 -9.26 -12.87 -19.79 -15.18 -18.31 -13.73 -89.86 -41.34 1.31 -4.88
Operating Profit Margin -0.62 -1.14 -19.63 -10.88 -6.15 -9.00 -15.32 -11.77 -15.89 -13.06 -81.17 -29.38 0.84 -2.10

๐Ÿ’ฐ Profit & Loss

Metric Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015 Mar 2014 Mar 2013
Sales 559.00 460.00 661.00 625.00 544.00 457.00 593.00 544.00 653.00 687.00 510.00 608.00
Interest 4.00 4.00 181.00 185.00 174.00 105.00 101.00 101.00 127.00 105.00 150.00 104.00
Expenses - 579.00 558.00 674.00 548.00 490.00 591.00 509.00 505.00 541.00 643.00 582.00 665.00
Other Income - 25.74 46.37 10.97 10.05 30.02 4.63 7.99 54.58 20.35 28.48 15.15 5.05
Exceptional Items 35.77 107.95 1,676 -1.49 -44.45 333.49 - 7.88 49.64 -0.57 167.52 -12.34
Depreciation 37.00 39.00 44.00 46.00 43.00 54.00 57.00 68.00 73.00 67.00 71.00 86.00
Profit Before Tax 1.00 13.00 1,449 -146.00 -178.00 45.00 -66.00 -67.00 -19.00 -99.00 -111.00 -253.00
Tax % 300.00 361.54 25.60 -1.37 -8.99 15.56 -15.15 16.42 -10.53 -9.09 -1.80 7.51
Net Profit - -2.00 -34.00 1,078 -148.00 -194.00 38.00 -76.00 -56.00 -21.00 -108.00 -113.00 -234.00
Profit From Associates - - - - - - - - 0.22 -5.81 -0.57 0.02
Minority Share 0.33 0.51 -0.02 -0.04 0.03 0.06 2.02 1.72 2.34 1.79 1.08 -
Exceptional Items At 32.79 61.40 1,275 -0.04 -34.45 325.78 - 7.88 48.24 -0.55 165.84 -12.27
Profit For PE -26.75 -93.71 -196.98 -147.62 -159.83 -288.11 -73.98 -62.12 -61.06 -105.97 -276.39 -222.01
Profit For EPS -1.17 -33.24 1,078 -147.70 -194.27 37.73 -73.98 -54.48 -18.29 -106.51 -112.13 -234.28
EPS In Rs -0.19 -5.42 175.91 -24.09 -31.69 6.15 -12.07 -8.89 -2.98 -17.38 -18.29 -38.22
PAT Margin % -0.36 -7.39 163.09 -23.68 -35.66 8.32 -12.82 -10.29 -3.22 -15.72 -22.16 -38.49
PBT Margin 0.18 2.83 219.21 -23.36 -32.72 9.85 -11.13 -12.32 -2.91 -14.41 -21.76 -41.61
Tax 3.00 47.00 371.00 2.00 16.00 7.00 10.00 -11.00 2.00 9.00 2.00 -19.00
Adj Ebit -31.26 -90.63 -46.03 41.05 41.02 -183.37 34.99 25.58 59.35 5.48 -127.85 -137.95
Adj EBITDA 5.74 -51.63 -2.03 87.05 84.02 -129.37 91.99 93.58 132.35 72.48 -56.85 -51.95
Adj EBITDA Margin 1.03 -11.22 -0.31 13.93 15.44 -28.31 15.51 17.20 20.27 10.55 -11.15 -8.54
Adj Ebit Margin -5.59 -19.70 -6.96 6.57 7.54 -40.12 5.90 4.70 9.09 0.80 -25.07 -22.69
Adj PAT -73.54 -316.33 2,325 -149.51 -242.45 319.60 -76.00 -49.41 33.87 -108.62 57.54 -245.41
Adj PAT Margin -13.16 -68.77 351.75 -23.92 -44.57 69.93 -12.82 -9.08 5.19 -15.81 11.28 -40.36
Ebit -67.03 -198.58 -1,722 42.54 85.47 -516.86 34.99 17.70 9.71 6.05 -295.37 -125.61
EBITDA -30.03 -159.58 -1,678 88.54 128.47 -462.86 91.99 85.70 82.71 73.05 -224.37 -39.61
EBITDA Margin -5.37 -34.69 -253.89 14.17 23.62 -101.28 15.51 15.75 12.67 10.63 -43.99 -6.51
Ebit Margin -11.99 -43.17 -260.55 6.81 15.71 -113.10 5.90 3.25 1.49 0.88 -57.92 -20.66
NOPAT 114.00 358.31 -42.41 31.42 11.99 -158.75 31.09 -24.24 43.11 -25.09 -145.57 -132.26
NOPAT Margin 20.39 77.89 -6.42 5.03 2.20 -34.74 5.24 -4.46 6.60 -3.65 -28.54 -21.75
Operating Profit -57.00 -137.00 -57.00 31.00 11.00 -188.00 27.00 -29.00 39.00 -23.00 -143.00 -143.00
Operating Profit Margin -10.20 -29.78 -8.62 4.96 2.02 -41.14 4.55 -5.33 5.97 -3.35 -28.04 -23.52

๐Ÿฆ Balance Sheet

Metric Sep 2024 Mar 2024 Sep 2023 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017
Accumulated Depreciation - 744.66 - 730.88 695.41 652.92 617.25 587.34 656.87 598.70
Advance From Customers - 78.00 - 77.00 172.00 65.00 15.00 12.00 10.00 12.00
Average Capital Employed 857.00 859.50 - 883.50 747.50 762.50 965.50 1,120 1,304 1,449
Average Invested Capital 712.50 700.00 - 589.50 516.00 769.50 999.00 1,192 1,392 1,546
Average Total Assets 1,258 1,256 - 1,515 1,468 1,284 1,383 1,487 1,694 1,822
Average Total Equity 836.00 844.49 - 859.49 321.00 -18.00 271.50 326.50 336.50 408.15
Cwip 84.00 102.00 52.00 42.00 17.00 34.00 24.00 23.00 40.00 30.00
Capital Employed 850.00 859.00 864.00 860.00 907.00 588.00 937.00 994.00 1,247 1,360
Cash Equivalents 140.00 139.00 148.00 226.00 583.00 136.00 90.00 23.00 23.00 14.00
Fixed Assets 597.00 582.00 624.00 600.00 622.00 609.00 657.00 806.00 949.00 1,001
Gross Block - 1,327 - 1,331 1,317 1,262 1,275 1,393 1,606 1,600
Inventory 167.00 178.00 200.00 202.00 213.00 174.00 148.00 81.00 334.00 316.00
Invested Capital 665.00 669.00 760.00 731.00 448.00 584.00 955.00 1,043 1,341 1,442
Investments 37.00 40.00 34.00 13.00 5.00 - 6.00 5.00 7.00 7.00
Loans N Advances 7.00 13.00 - 10.00 13.00 14.00 16.00 28.00 24.00 47.00
Long Term Borrowings 21.57 20.99 20.62 20.16 34.10 735.08 613.13 46.12 570.71 714.06
Net Debt -155.00 -158.00 -161.00 -219.00 -554.00 684.00 646.00 618.00 911.00 973.00
Net Working Capital -16.00 -15.00 84.00 89.00 -191.00 -59.00 274.00 214.00 352.00 411.00
Non Controlling Interest -4.00 -4.00 -4.00 -3.00 -3.00 -3.00 -3.00 -3.00 -3.00 11.00
Other Asset Items 147.00 129.00 136.00 118.00 224.00 126.00 381.00 320.00 84.00 231.00
Other Borrowings - - - - 0.01 - 125.49 530.99 205.16 88.81
Other Liability Items 223.00 150.00 233.00 157.00 445.00 278.00 239.00 100.00 64.00 168.00
Reserves 827.00 841.99 841.00 841.98 871.00 -235.00 193.00 344.00 303.00 350.00
Share Capital 6.00 6.00 6.00 6.00 6.00 6.00 6.00 6.00 6.00 6.00
Short Term Borrowings - - 0.06 0.06 0.05 84.45 3.57 69.39 164.88 190.71
Short Term Loans And Advances - 3.00 2.00 60.00 60.00 61.00 60.00 17.00 13.00 9.00
Total Assets 1,243 1,241 1,272 1,271 1,759 1,178 1,390 1,376 1,598 1,789
Total Borrowings 22.00 21.00 21.00 20.00 34.00 820.00 742.00 646.00 941.00 994.00
Total Equity 829.00 843.99 843.00 844.98 874.00 -232.00 196.00 347.00 306.00 367.00
Total Equity And Liabilities 1,243 1,241 1,272 1,271 1,759 1,178 1,390 1,376 1,598 1,789
Total Liabilities 414.00 397.01 429.00 426.02 885.00 1,410 1,194 1,029 1,292 1,422
Trade Payables 170.00 154.00 175.00 177.00 235.00 247.00 199.00 270.00 277.00 249.00
Trade Receivables 63.00 57.00 154.00 120.00 164.00 170.00 138.00 178.00 272.00 284.00

๐Ÿ’ต Cash Flows

Metric Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017
Cash From Financing Activity -3.00 -18.00 -1,176 -47.00 91.00 -101.00 -164.00 -107.00
Cash From Investing Activity 10.00 430.00 1,283 -48.00 -35.00 -6.00 55.00 -26.00
Cash From Operating Activity - -422.00 -108.00 107.00 -30.00 105.00 118.00 131.00
Cash Invested In Inter Corporate Deposits 142.00 1,083 - - - - - -
Cash Paid For Acquisition Of Companies - - - - - - -8.00 -
Cash Paid For Loan Advances -27.96 -30.79 11.78 -26.50 -2.04 16.32 -24.83 -7.08
Cash Paid For Purchase Of Fixed Assets -78.00 -41.00 -13.00 -22.00 -7.00 -5.00 -15.00 -24.00
Cash Paid For Purchase Of Investments -302.00 -212.00 -5.00 - -7.00 -1.00 -2.00 -
Cash Paid For Redemption And Cancellation Of Shares - - - 6.00 - - 80.00 -
Cash Paid For Repayment Of Borrowings -0.24 -14.77 -786.36 -48.92 -639.21 -34.75 -64.65 -70.98
Cash Received From Borrowings - - 0.30 101.20 743.00 - 9.80 63.32
Cash Received From Sale Of Fixed Assets 7.00 40.00 2.00 4.00 16.00 - - -
Cash Received From Sale Of Investments 278.00 205.00 - - - 2.00 2.00 2.00
Change In Inventory 24.16 10.63 -38.58 -26.45 -66.26 84.76 -18.83 -9.16
Change In Other Working Capital Items 10.54 -323.65 374.00 91.71 0.38 -16.01 29.37 15.13
Change In Payables - - - - -49.69 7.51 31.27 62.87
Change In Receivables 2.96 6.89 -46.34 -16.86 20.11 34.74 4.46 -18.44
Change In Working Capital 9.69 -336.91 300.86 21.91 -97.50 127.32 21.45 43.32
Direct Taxes Paid -2.51 -2.48 -403.70 -1.00 -8.67 1.83 -3.91 4.95
Dividends Paid - - - - - - - -
Dividends Received - - - - - - - -
Interest Paid -2.57 -3.60 -389.79 -99.40 -45.03 -66.39 -109.50 -99.30
Interest Received 8.00 12.00 3.00 3.00 5.00 1.00 - 2.00
Loans Given To Related Parties - - - - - - - -
Net Cash Flow 7.00 -10.00 -2.00 12.00 26.00 -2.00 9.00 -2.00
Other Cash Financing Items Paid - - - - 31.97 - - -
Other Cash Investing Items Paid -46.00 -656.00 1,295 -39.00 -42.00 -3.00 -2.00 -6.00
Profit From Operations -7.28 -83.06 -5.61 85.85 75.70 -24.35 100.48 82.39

๐Ÿงพ Shareholding Pattern

Nse Code Date Promoters Fii Dii Public Others
Panaceabio 2024-12-31 - 0.38 1.16 25.96 0.00
Panaceabio 2024-09-30 - 0.37 1.16 25.60 0.00
Panaceabio 2024-06-30 - 0.26 1.07 25.21 0.00
Panaceabio 2024-03-31 - 0.27 0.84 25.30 0.00
๐Ÿ’ฌ
Stock Chat